Skip to main content
Create Account
Training Center
Contact Us
Questions? Comments?
Contact us.
Email:
PLUS@pli.edu
Phone:
877.900.5291
PLI.edu
SIGN IN
Search
Browse
All Content
Books
- Answer Books
- Course Handbooks
- Journals
- Insights
- Treatises
Forms & Checklists
Transcripts
My Bookshelf
My History
< Back To Results
1 in 1 results
Previous Result
Next Result
Developments in Pharmaceutical and Biotech Patent Law 2020
Chair(s):
Daniel L. Reisner
Practice Area:
Biotechnology,
Intellectual property,
Life sciences,
Patents,
Pharmaceuticals
Published:
Dec 2020
i
Other versions can be found in the
Related Items
tab.
ISBN:
9781402437670
PLI Item #:
277950
CHB Spine #:
G1489
This version is not current.
Click here for the most recent version.
Search
Email
Print
Add To Bookshelf
Permalink
Table of Contents
Related Items
Select All
Front Matter
Faculty Bios
Table of Contents
Chapter 1. Recent Developments in Written Description and Enablement for Small Molecule and Biologic Patents
Chapter 2. Daniel L. Reisner, Aaron Stiefel, Richard G. Greco, Krista M. Rycroft and Sapna Walter Palla, Excerpt from Ch. 5: Patentability, Practising Law Institute, Pharmaceutical and Biotech Patent Law, §§ 5:4 and 5:5 (March 2020)
Chapter 3. Biologic and Biosimilar Drug Products, Practising Law Institute, Pharmaceutical and Biotech Patent Law, Ch. 14 (September 2020)
Chapter 4. Strategic Considerations in Inter Partes Reviews of Life Sciences Patents
Chapter 5. Application of the Doctrine of Equivalents in Recent Pharmaceutical and Biotech Patent Cases (September 14, 2020)
Chapter 6. Legal Principles Every IP Due Diligence Lawyer in Life Sciences Should Know (September 14, 2020)
Chapter 7. Sanjay K. Murthy and Michael T. Sikora, Ethics for Life Sciences Patent Lawyers
Index
About Us